whats the exit way of one year biotech analyst role at a very small investment bank?

I am an international student with degrees in biomedical science and finance. I worked as a Research Associate for one year in the gene therapy field but realized that academia wasn’t the right fit for me. Currently, I’m working as a biotech analyst at a very small investment bank (10–20 people), directly collaborating with the Managing Director on biotech deals.

However, my situation has changed recently as my boss informed me that the company won’t be able to support my work visa after my 3-year OPT. I’m now exploring options to address my immigration challenges.

After six months of job hunting, I’ve faced setbacks, including failing two final-round interviews with MBB and not securing enough other opportunities. I’m seeking career advice and suggestions. Thank you!

4 Comments
 

Based on the most helpful WSO content, here are some actionable steps and insights for your situation:

  1. Leverage Your Biotech and Finance Background: Your unique combination of biomedical science and finance makes you a strong candidate for roles in biotech-focused private equity (PE), venture capital (VC), or corporate development within biotech/pharma companies. These sectors value your technical expertise and deal experience.

  2. Target International-Friendly Firms: Focus on firms known to sponsor H1-B visas. Some BBs (Bulge Bracket), EBs (Elite Boutiques), and larger MMs (Middle Market banks) are more likely to sponsor compared to smaller firms. Networking with alumni or professionals in these firms can help you identify opportunities.

  3. Explore Overseas Opportunities: If staying in the U.S. becomes unfeasible, consider transferring to offices in regions like London, Hong Kong, or Singapore, where visa sponsorship might be less of a hurdle. Many international analysts have successfully transitioned to these locations.

  4. Corporate Development Roles: Many biotech and pharma companies have corporate development teams that work on M&A and strategic partnerships. These roles often align well with your background and may offer visa sponsorship.

  5. Networking and Headhunters: Build relationships with headhunters specializing in biotech or finance roles. They can provide insights into firms that are open to hiring international candidates. Additionally, leverage your network to connect with professionals in your target roles.

  6. Consider STEM OPT Extension: If your current role qualifies under STEM OPT, you may be eligible for a 24-month extension. Confirm with your employer and school’s international office if this applies to you.

  7. Reassess MBB Strategy: If MBB consulting remains a goal, consider refining your interview preparation. Seek feedback on your past interviews, practice case studies rigorously, and network with consultants who can provide insights into the process.

  8. Plan for Long-Term Immigration: Explore alternative visa options, such as the O-1 visa for individuals with extraordinary ability, or the Diversity Visa (DV) lottery if eligible. Additionally, some countries offer immigration pathways for skilled professionals in biotech and finance.

  9. Short-Term Financial Planning: Avoid long-term financial commitments in the U.S. until your visa situation stabilizes. This ensures flexibility in case you need to relocate.

  10. Stay Resilient: The job market for internationals can be challenging, but persistence and strategic planning often pay off. Keep refining your approach and exploring new opportunities.

For further insights, you can explore threads like: - https://www.wallstreetoasis.com/forum/investment-banking/advice-for-int…</a">Advice for International Students in the US (F-1 Visa, OPT, CPT, H-1B) - https://www.wallstreetoasis.com/forum/investment-banking/what-happens-t…</a">What happens to international students?

Good luck navigating this challenging phase!

Sources: https://www.wallstreetoasis.com/forum/investment-banking/what-happens-to-international-students?customgpt=1, What happens to international students?, Healthcare IB eligible for STEM OPT?, My Advice for International Students in the US (F-1 Visa, OPT, CPT, H-1B), What are the chances for an Asian international student for IBD?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Explicabo odit accusamus soluta ut. Quisquam deserunt quisquam enim debitis quae. Aliquam accusamus alias est dicta veniam praesentium hic adipisci. Non incidunt perferendis optio fugit cupiditate rerum qui.

Sint libero id autem aut. Sequi impedit earum dolore aliquam aut qui. Quos accusamus voluptas quos.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
DrApeman's picture
DrApeman
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”